Care Access, a global clinical research company helping to accelerate the future of medicine, is bringing its Heart & Kidney Health Screening initiative to Chicago, Ilinois. This health screening aims to raise awareness and provide testing for certain health risk factors, including a dangerous type of cholesterol known as lipoprotein(a), or Lp(a), which impacts one in five people and significantly increases the risk of heart disease and stroke.
Despite the prevalence of Lp(a) and its impact on cardiovascular health, most people are unaware of their Lp(a) levels due to limited access to testing. It is critical to raise community awareness of this risk factor as there are no currently approved medicines for lowering Lp(a) and it is not impacted by a healthy diet or exercise.
The Heart & Kidney Health Screening offers no-cost Lp(a) testing as well as screenings for other related metabolism and kidney risks. The screenings are part of the Future of Medicine program by Care Access which not only provides crucial health information to participants but also encourages community involvement in clinical trials for potential new treatments targeting Lp(a) and other conditions.
The Future of Medicine program features three key components:
No-Cost Testing: No-cost screenings for certain heart and kidney risks, including Lp(a), to provide individuals valuable information about their health.
Health Education: Information to raise awareness about cardiovascular health and the importance of clinical research in advancing medical treatments.
Clinical Trial Awareness: Assistance in finding local clinical trial opportunities and promoting community engagement in medical research.
Care Access will host screening events on November 11-14 at Michelle’s Ballroom, located at 2800 W Belmont Avenue in Chicago. Walk-ins are available, but scheduling is recommended at MyFreeHeartTest.com.
“Regular screenings are key to understanding and managing heart health. Care Access’s initiative in offering Lp(a) testing alongside other screenings fills an important gap in preventive care,” said Dr. Sinikka Green, Medical Director and Principal Investigator at Care Access.
